default image

Urologie

Information and services of the department

  • Number of inpatient cases: 140

Services search (in the department)


Illness Number of cases
Malignant neoplasm of bladder - Malignant neoplasm of overlapping sites of bladder (C67.8) 30
Malignant neoplasm of bladder - Malignant neoplasm of bladder unspecified (C67.9) 26
Hyperplasia of prostate (N40) 25
Malignant neoplasm of prostate (C61) 10
Cystitis (N30.2) 6
Urethral stricture (N35.8) 6
Candidiasis (B37.4) not specified
Malignant neoplasm of testis (C62.9) not specified
Malignant neoplasm of renal pelvis (C65) not specified
Malignant neoplasm of bladder - Malignant neoplasm of lateral wall of bladder (C67.2) not specified
Treatment Number
Injection or administration of medicines into the urinary bladder (8-132.3) 94
Surgical incision, removal or destruction of diseased tissue in the urinary bladder, with access through the urethra (5-573.40) 80
Surgical removal or destruction of prostatic tissue through the urethra (5-601.0) 31
Instillation into a body cavity and locally restricted treatment with chemotherapy drugs or agents that influence the immune system (8-541.4) 17
Surgical incision into diseased tissue in the urethra, with access through the urethra (5-585.1) 9
(9-984.6) 8
(9-984.7) 8
Surgical incision into diseased tissue in the urethra, with access through the urethra (5-585.0) 5
Operation on the foreskin of the penis (5-640.2) 5
Taking a tissue sample (biopsy) of the male reproductive organs through the rectum (1-464.01) 4

Hospital information and services for all specialist departments

External comparative quality assurance
Further information
  • External quality assurance according to state law
    No participation
Number Group
109 Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training*
74 Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence
74 Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations
* according to the “Provisions of the Joint Federal Committee for the Further Training of Medical Specialists (m/f), Psychological Psychotherapists (m/f) and Child and Adolescent Psychotherapists (m/f) in Hospitals”
Job Explanation
Doctoral supervision
Participation in multi-centre phase III/IV studies u.a. HypoSIB-Studie (MammaCa), HD-Studien (Hodgkins-Desease/Lymphome), Mukositis-Studie
Project-related cooperation with colleges and universities
Student training (clinical traineeship / internship year) Vorlesungen, u.a. auch Beteiligung an der Ausbildung von Medizinphysik-Studenten (Master/Bachelor)
Initiation and management of uni-centric/multi-centric clinical/scientific studies
Lectureships / teaching posts at colleges and universities Universität des Saarlandes, Texas Tech University, University Medical Center and Southwest Cancer Treatment Center, Lubbock, Texas, USA; Universität zu Köln; Westfälische Wilhelms-Universität Münster;Semmelweis-Universität Budapest; University of London, Universität Heidelberg
Lectureships / teaching posts at universities of applied sciences HTW - Hochschule für Technik und Wirtschaft des Saarlandes, HFH (Hamburger Fernhochschule)
Editors of scientific journals/textbooks z.B. Lehrbuch Klinische Radiologie Fakten, 08. Auflage, Pickuth, Dirk; Strahlentherapie, 02. Auflage, Wannemacher, Wenz, Debus, Pickuth, Dirk; "HEALTHCARE EXECUTIVES - The Essentials for Excellence in Leadership and Management", Pickuth, Dirk; Taschenbuch Onkologie, Co Autor Metzger, Ralf
No. Training in other healing professions Comment
HB19 Nursing professionals
HB09 Speech therapist (m/f)
HB07 Surgical technical assistant (m/f)
HB17 Auxiliary nurse (m/f)
HB10 Midwife (m/f)
HB15 Anaesthesia technical assistant (m/f)

Gisela Wittmann

ehrenamtliche Patientenfürsprecherin

Phone: 0681 -406-2856
Mail: ed.mukinilksatirac@nirehcerpsreufnetneitap

Dr.-Ing. Bettina Hahne

Leiterin Qualitätsmanagement

Phone: 0681 -406-2898
Mail: ed.mukinilksatirac@tnemeganamedrewhcseb

Dr.-Ing. Bettina Hahne

Leiterin Qualitätsmanagement

Phone: 0681 -406-2898
Mail: ed.mukinilksatirac@enhah.b

Margret Reiter

Ärztliche Direktorin, Kaufmännische Direktorin

Phone: 0681 -406-2802
Mail: ed.mukinilksatirac@ofni

Anja Eisermann

Leiterin der Apotheke

Phone: 0681 -406-2940
Mail: ed.mukinilksatirac@nnamresie.a